JCM
AMED

Julex Capital Management’s Amedisys AMED Stock Holding History

Julex Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$5K Buy
+37
New +$4.82K 0.01% 54

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Julex Capital Management's AMED Position: Q3 2019 in Review

Julex Capital Management opened a new position in Amedisys (AMED) in Q3 2019: 37 shares worth $5K. The stake represents 0.01% of the portfolio and ranks #54 among its holdings.

283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

  • Julex Capital Management held 37 shares of Amedisys worth $5K as of Q3 2019.
  • Amedisys was a new Julex Capital Management position in Q3 2019.
  • Amedisys made up 0.01% of Julex Capital Management's portfolio in Q3 2019, its #54 holding.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Julex Capital Management's 13F filing for Q3 2019, filed 18 Oct 2019.